838 results on '"DeMets, David L"'
Search Results
2. Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
3. Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19
4. Abstract 18437: Efficacy and Safety of Dapagliflozin in Patients With Heart Failure and Previous Myocardial Infarction
5. Correction to: Fundamentals of Clinical Trials
6. Research Integrity: The Roles of Academicians, Their Institutions, and Other Agencies
7. Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions
8. The Case for Access to Data Monitoring Committee Charters.
9. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
10. Society for Clinical Trials Data Monitoring Committee initiative website: Closing the gap
11. Establishing and Maintaining Research Integrity at Academic Institutions: Challenges and Opportunities
12. Data and Safety Monitoring
13. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
14. Sample Size
15. The Randomization Process
16. Blinding
17. Baseline Assessment
18. Ethical Issues
19. Basic Study Design
20. Study Population
21. What Is the Question?
22. Issues in Data Analysis
23. Closeout
24. Survival Analysis
25. Regulatory Issues
26. Multicenter Trials
27. Reporting and Interpreting of Results
28. Introduction to Clinical Trials
29. Monitoring Committee Structure and Function
30. Statistical Methods Used in Interim Monitoring
31. Data Collection and Quality Control
32. Participant Adherence
33. Assessment of Health Related Quality of Life
34. Recruitment of Study Participants
35. Assessment and Reporting of Harm
36. Bringing data monitoring committee charters into the sunlight
37. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years
38. Data Monitoring Committees in Clinical Trials
39. Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
40. Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
41. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
42. Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
43. Where the Jobs Are: A Study of Amstat News Job Advertisements
44. Estimating and Reducing Bias in Group Sequential Designs with Gaussian Independent Increment Structure
45. Sequential Monitoring of Clinical Trials with Correlated Responses
46. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial
47. The Randomization Process
48. Baseline Assessment
49. What Is the Question?
50. Basic Study Design
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.